We are thrilled to announce that Retro Biosciences has successfully raised an impressive $1 billion in our latest funding round. Founded with the bold ambition of adding a decade to the healthy human lifespan, Retro Biosciences is at the forefront of groundbreaking research focused on cellular reprogramming, autophagy, and plasma-inspired therapeutics. The funds raised will significantly accelerate our innovative projects, allowing us to deepen our understanding of the aging process and develop transformative solutions that aim to enhance longevity and health span. This funding will enable us to expand our research team, increase our laboratory capabilities, and fast-track the clinical development of our pioneering therapies. By harnessing the power of cutting-edge science, we are committed to unlocking the secrets of cellular rejuvenation and mitigating the effects of aging, ultimately empowering individuals to not just live longer, but live healthier, more vibrant lives. With the support of our investors who share our vision of pioneering age-related health breakthroughs, we are poised to make significant strides toward our goal. We are excited about the road ahead and anticipate a future where the dream of extending healthy lifespan becomes a reality for all. Thank you to our supporters and stakeholders who believe in our mission; together, we will redefine the meaning of aging and enhance the experience of life itself. Stay tuned for updates as we embark on this extraordinary journey!










.png&w=3840&q=75)


